Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors (NCT06716138) | Avistone Biotechnology Co., Ltd. | 2025-03-06 |
Track Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration automatically
Every clearance here is in the API, with alerts when new ones post.